Want to see AU:S66 full AI Analyst Report?
Total Valuation
Star Combo Pharma Ltd. has a market cap or net worth of AU$18.90M. The enterprise value is AU$4.42.
Market CapAU$18.90M
Enterprise ValueAU$4.42
Share Statistics
Star Combo Pharma Ltd. has 135,002,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding135,002,980
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Star Combo Pharma Ltd.’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is -0.39%.
Return on Equity (ROE)0.01
Return on Assets (ROA)<0.01
Return on Invested Capital (ROIC)-0.39%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee785.77K
Profits Per Employee13.15K
Employee Count30
Asset Turnover0.47
Inventory Turnover5.43
Valuation Ratios
The current PE Ratio of Star Combo Pharma Ltd. is 48.3. Star Combo Pharma Ltd.’s PEG ratio is -0.52.
PE Ratio48.3
PS Ratio0.77
PB Ratio0.47
Price to Fair Value0.47
Price to FCF22.17
Price to Operating Cash Flow5.77
PEG Ratio-0.52
Income Statement
In the last 12 months, Star Combo Pharma Ltd. had revenue of 23.57M and earned 394.61K in profits. Earnings per share was <0.01.
Revenue23.57M
Gross Profit4.99M
Operating Income-231.10K
Pretax Income528.47K
Net Income394.61K
EBITDA1.24M
Earnings Per Share (EPS)<0.01
Cash Flow
In the last 12 months, operating cash flow was 3.28M and capital expenditures -2.45M, giving a free cash flow of 822.64K billion.
Operating Cash Flow3.28M
Free Cash Flow822.64K
Free Cash Flow per Share<0.01
Dividends & Yields
Star Combo Pharma Ltd. pays an annual dividend of AU$0.003, resulting in a dividend yield of 2.64%
Dividend Per ShareAU$0.003
Dividend Yield2.64%
Payout Ratio9.25%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.71
52-Week Price Change-30.00%
50-Day Moving Average0.13
200-Day Moving Average0.19
Relative Strength Index (RSI)66.05
Average Volume (3m)6.77K
Important Dates
Star Combo Pharma Ltd. upcoming earnings date is Feb 23, 2027, TBA (Confirmed).
Last Earnings DateAug 25, 2026
Next Earnings DateFeb 23, 2027
Ex-Dividend Date―
Financial Position
Star Combo Pharma Ltd. as a current ratio of 3.86, with Debt / Equity ratio of 10.79%
Current Ratio3.86
Quick Ratio3.33
Debt to Market Cap0.02
Net Debt to EBITDA0.23
Interest Coverage Ratio-1.15
Taxes
In the past 12 months, Star Combo Pharma Ltd. has paid 133.87K in taxes.
Income Tax133.87K
Effective Tax Rate0.25
Enterprise Valuation
Star Combo Pharma Ltd. EV to EBITDA ratio is 14.89, with an EV/FCF ratio of 22.51.
EV to Sales0.79
EV to EBITDA14.89
EV to Free Cash Flow22.51
EV to Operating Cash Flow5.65
Balance Sheet
Star Combo Pharma Ltd. has AU$18.01M in cash and marketable securities with AU$4.19M in debt, giving a net cash position of AU$13.82M billion.
Cash & Marketable SecuritiesAU$18.01M
Total DebtAU$4.19M
Net CashAU$13.82M
Net Cash Per ShareAU$0.10
Tangible Book Value Per ShareAU$0.28
Margins
Gross margin is 21.17%, with operating margin of -0.98%, and net profit margin of 1.67%.
Gross Margin21.17%
Operating Margin-0.98%
Pretax Margin2.24%
Net Profit Margin1.67%
EBITDA Margin5.28%
EBIT Margin-0.98%
Analyst Forecast
The average price target for Star Combo Pharma Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-15.24%
EPS Growth Forecast-92.54%